enGene Holdings Inc (ENGN): Broker Consensus Forecast

Corporate company logo of enGene Holdings Inc (ENGN)

enGene Holdings Inc. (ENGN) brings together leading immunologists and geneticists, creating an environment for scientific breakthroughs through a system of long-term options and R&D budgets. This chart illustrates the asset's price action, with its current value standing at 4.39. The business's profit potential relies on the commercialization of gene therapy methods for oncological diseases and the creation of innovative systems for the non-contact transport of genetic code into tissues.

enGene Holdings Inc (ENGN) Price Target Chart: for the period 02/21/2024 - 11/17/2026

Analytical breakdowns for enGene Holdings Inc. (ENGN)

- current quotes and average value forecast:
- stock exchange capitalization data:
General company analysis:ENGN enGene Holdings Inc
Flagship merchandise of enGene Corp

For enGene Holdings Inc. (ENGN), which is currently in the clinical trial phase for oncology drugs, the consolidated target price forecast from investment banks serves as an indicator of market confidence in the success of upcoming commercialization. This metric aggregates expert expectations regarding fair value, where a stable trend confirms confidence in management's strategy, while sharp fluctuations signal a reassessment of the risks associated with the development of the gene delivery platform.

Competitors of enGene Holdings Inc.

Analyst Consensus Forecast argenx N.V. (ARGX)|Price Target Chart BioNTech SE BNTX|Abivax Corp - Price Target Chart|ADMA - Price Target Chart|Analyst Target Range Protagonist (PTGX)|IMVT (Immunovant, Inc.) - Consensus Target|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Analyst Consensus Forecast|Price Target Chart Grifols|Adaptive Biotechnologies Corp - Forecast Levels Chart|Analyst Consensus Forecast CLDX|AUPH (Aurinia Pharmaceuticals) - Fair Value Consensus|Analyst Consensus Forecast BCRX (biocryst.com)|Analyst Consensus Forecast Vera Therapeutics Inc VERA|DNTH - Price Target Chart|Fair Value Consensus PHVS (Pharvaris Pharma)|AbCellera Corp (ABCL) - Price Target Chart|Consensus Target Tourmaline Bio, Inc.|PGEN (precigen.com) - Analyst Consensus Forecast|Analyst Consensus Forecast Pharming|Consensus Target NKTR (Nektar)|Analyst Median Target Upstream Pharma|Analyst Consensus Forecast ZBIO (zenasbio.com)|Analyst Median Target immunome.com (IMNM)|GOSS - Price Target Chart|KalVista Pharma (KALV) - Consensus Target|Septerna Pharma (SEPN) - Price Target Chart|Consensus Target Pieris Pharmaceuticals|Consensus Target SVRA|Analyst Consensus Forecast rigel.com|Price Target Chart AnaptysBio Corp (ANAB)|Astria Therapeutics, Inc. - Broker Consensus Forecast|Analyst Consensus Forecast RAPT (rapt.com)|Aerovate (JBIO) - Average Forecast Price|Aclaris Therapeutics, Inc - Analyst Consensus Forecast|KYTX - Analyst Consensus Forecast|TLSA: Analyst Consensus Forecast|Cabaletta Bio (CABA) - Analyst Consensus Forecast|Price Target Chart Ventyx Biosciences|Average Forecast Price Theratechnologies, Inc THTX|Price Target Chart Avalo Therapeutics, Inc (AVTX)|eledon.com - Broker Consensus Forecast|agenusbio.com - Consensus Target|Climb Bio, Inc. - Price Target Chart|Zura Bio - Analyst Consensus Forecast|Forecast Levels Chart ATYR|ADAG: Analyst Consensus Forecast|IMA (ImageneBio) - Price Target Chart|Price Target Chart Shattuck Therapeutics|EQ: Fair Value Consensus|Analyst Consensus Forecast CNTB|Analyst Median Target Immunic Therapeutics|Atara Bio - Consensus Target|Analyst Median Target inflarx.de (IFRX)|XFOR (X4 Pharmaceuticals Inc.) - Average Forecast Price|ACET - Analyst Consensus Forecast|CELU: Analyst Consensus Forecast|INMB - Analyst Median Target|Price Target Chart Barinthus Biotherapeutics PLC|Kezar Life Sciences (KZR) - Analyst Median Target|Analyst Consensus Forecast SABS|Analyst Consensus Forecast Akari Therapeutics plc (AKTX)|Analyst Consensus Forecast ENLV (Enlivex Therapeutics Ltd.)|Q32 Bio Inc. - Price Target Chart|GOVX: Consensus Target|EDSA (Edesa Biotech, Inc.) - Broker Consensus Forecast|iBio (IBIO) - Price Target Chart|CARM: Analyst Forecast Prices|XTLB (XTL Bio) - Analyst Consensus Forecast|Bolt Biotherapeutics (BOLT) - Analyst Median Target|Analyst Consensus Forecast HCWB|Analyst Median Target Aptevo Therapeutics Inc.|Price Target Chart AIM ImmunoTech AIM|ADTX - Consensus Target|GRI: Consensus Target|XRTX (XORTX) - Broker Consensus Forecast|HIND: Analyst Consensus Forecast|REVB - Analyst Median Target|Price Target Chart Indaptus|Scinai Immunotherapeutics Ltd. (SCNI) - Analyst Median Target|Price Target Chart CalciMedica Inc (CALI)|AFMD - Average Forecast Price|Price Target Chart Allakos Inc. ALLK|Fair Value Consensus HOOK|IGM Biosciences - Analyst Consensus Forecast|Fair Value Consensus ITOS (iTeos Therapeutics Inc)|OCEA: Analyst Consensus Forecast|Broker Consensus Forecast TCBP|THRD (Third Harmonic Bio Inc) - Analyst Consensus Forecast